272 related articles for article (PubMed ID: 10493747)
1. Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligodendrocytes.
Oh LY; Larsen PH; Krekoski CA; Edwards DR; Donovan F; Werb Z; Yong VW
J Neurosci; 1999 Oct; 19(19):8464-75. PubMed ID: 10493747
[TBL] [Abstract][Full Text] [Related]
2. Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum.
Vaillant C; Didier-Bazès M; Hutter A; Belin MF; Thomasset N
J Neurosci; 1999 Jun; 19(12):4994-5004. PubMed ID: 10366632
[TBL] [Abstract][Full Text] [Related]
3. The expression of matrix metalloproteinase-12 by oligodendrocytes regulates their maturation and morphological differentiation.
Larsen PH; Yong VW
J Neurosci; 2004 Sep; 24(35):7597-603. PubMed ID: 15342725
[TBL] [Abstract][Full Text] [Related]
4. Oligodendrocytes utilize a matrix metalloproteinase, MMP-9, to extend processes along an astrocyte extracellular matrix.
Uhm JH; Dooley NP; Oh LY; Yong VW
Glia; 1998 Jan; 22(1):53-63. PubMed ID: 9436787
[TBL] [Abstract][Full Text] [Related]
5. Expression of matrix metalloproteinases during murine chorioallantoic placenta maturation.
Teesalu T; Masson R; Basset P; Blasi F; Talarico D
Dev Dyn; 1999 Mar; 214(3):248-58. PubMed ID: 10090151
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
7. Cloning of murine membrane-type-1-matrix metalloproteinase (MT-1-MMP) and its metanephric developmental regulation with respect to MMP-2 and its inhibitor.
Ota K; Stetler-Stevenson WG; Yang Q; Kumar A; Wada J; Kashihara N; Wallner EI; Kanwar YS
Kidney Int; 1998 Jul; 54(1):131-42. PubMed ID: 9648071
[TBL] [Abstract][Full Text] [Related]
8. Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter.
Beliën AT; Paganetti PA; Schwab ME
J Cell Biol; 1999 Jan; 144(2):373-84. PubMed ID: 9922462
[TBL] [Abstract][Full Text] [Related]
9. Inter-regulated balance between gelatinases and tissue inhibitor (TIMP-1) in isolated human glomeruli.
Zaoui P; Barro C; Maynard C; Descotes JL; Maurizi-Balzan J; Cordonnier DJ; Morel F
Ren Fail; 1998 Mar; 20(2):201-9. PubMed ID: 9574444
[TBL] [Abstract][Full Text] [Related]
10. Regulated expression of matrix metalloproteinases and TIMP in nephrogenesis.
Tanney DC; Feng L; Pollock AS; Lovett DH
Dev Dyn; 1998 Sep; 213(1):121-9. PubMed ID: 9733107
[TBL] [Abstract][Full Text] [Related]
11. Expression of matrix metalloproteinases and their inhibitor TIMP-1 in the rat carotid artery after balloon injury.
Webb KE; Henney AM; Anglin S; Humphries SE; McEwan JR
Arterioscler Thromb Vasc Biol; 1997 Sep; 17(9):1837-44. PubMed ID: 9327785
[TBL] [Abstract][Full Text] [Related]
12. Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption.
Kusano K; Miyaura C; Inada M; Tamura T; Ito A; Nagase H; Kamoi K; Suda T
Endocrinology; 1998 Mar; 139(3):1338-45. PubMed ID: 9492070
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas.
Kossakowska AE; Edwards DR; Prusinkiewicz C; Zhang MC; Guo D; Urbanski SJ; Grogan T; Marquez LA; Janowska-Wieczorek A
Blood; 1999 Sep; 94(6):2080-9. PubMed ID: 10477738
[TBL] [Abstract][Full Text] [Related]
14. Expression and modulation of matrix metalloproteinase-2 and tissue inhibitors of metalloproteinases in human embryonic CNS stem cells.
Frölichsthal-Schoeller P; Vescovi AL; Krekoski CA; Murphy G; Edwards DR; Forsyth P
Neuroreport; 1999 Feb; 10(2):345-51. PubMed ID: 10203333
[TBL] [Abstract][Full Text] [Related]
15. Secretion of matrix metalloproteinase-2, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases into the intrauterine compartments during early pregnancy.
Riley SC; Leask R; Chard T; Wathen NC; Calder AA; Howe DC
Mol Hum Reprod; 1999 Apr; 5(4):376-81. PubMed ID: 10321811
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A.
Okada A; Tomasetto C; Lutz Y; Bellocq JP; Rio MC; Basset P
J Cell Biol; 1997 Apr; 137(1):67-77. PubMed ID: 9105037
[TBL] [Abstract][Full Text] [Related]
17. Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation.
Alexander CM; Hansell EJ; Behrendtsen O; Flannery ML; Kishnani NS; Hawkes SP; Werb Z
Development; 1996 Jun; 122(6):1723-36. PubMed ID: 8674412
[TBL] [Abstract][Full Text] [Related]
18. Modulation of MMP-2 (gelatinase A) and MMP-9 (gelatinase B) by interferon-gamma in a human salivary gland cell line.
Wu AJ; Lafrenie RM; Park C; Apinhasmit W; Chen ZJ; Birkedal-Hansen H; Yamada KM; Stetler-Stevenson WG; Baum BJ
J Cell Physiol; 1997 May; 171(2):117-24. PubMed ID: 9130458
[TBL] [Abstract][Full Text] [Related]
19. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
Kossakowska AE; Edwards DR; Lee SS; Urbanski LS; Stabbler AL; Zhang CL; Phillips BW; Zhang Y; Urbanski SJ
Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979
[TBL] [Abstract][Full Text] [Related]
20. Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP).
Sato H; Takino T; Kinoshita T; Imai K; Okada Y; Stetler Stevenson WG; Seiki M
FEBS Lett; 1996 May; 385(3):238-40. PubMed ID: 8647259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]